Call for Volunteers - ISPE Good Practice Guide: Maintenance 2nd Edition
The 2nd edition of the ISPE Good Practice Guide: Maintenance is currently under revision and the team leaders, Constantino Rodriguez (formerly Outlook Therapeutics) and George Wittman (JLL Chicago), are looking for additional volunteers to assist with specific chapters for the update. They are looking for subject matter experts to draft and/or edit content for the following topics as they relate to maintenance:
Environment, health, and safety in a maintenance environment
Maintenance templates and examples
As part of the authoring team, you would work closely with the team leaders to create technical content for a chapter/section of the document. You may also be involved with the review of other portions of the document. Team members are expected to work collaboratively with other authors while producing content. You must agree to be accountable for your aspect of the work by ensuring that comments are adequately resolved during the multiple review processes (including industry review).
If you are interested in participating in this Guide, please email your contact details, a brief description of your experience, and the specific topic(s) you would like to work on. Upon acceptance to the authoring team, you will be required to sign the ISPE Contributing Author Agreement form.
The ISPE 2023 Annual Meeting & Expo agenda is always packed with sessions offering pharmaceutical professionals opportunities to engage in industry-critical conversations. Several of ISPE's regulatory initiatives took center stage during the technical sessions in the Regulatory and Quality track at the
Just around the corner on 11-12 December, join us for a wealth of knowledge sharing, uniting industry experts to engage in discussions that unveil their insights and experiences through the 2023 ISPE Pharma 4.0™ and Annex 1 Conference.
On Wednesday, 18 October 2023, Dr. Celia Lourenco, Associate Assistant Deputy Minister of Health Canada's Health Products and Food branch, presented a keynote address titled “Advanced Manufacturing and Other Trends Supporting Access to Medicines for Patients” at the